Investment in AXE is and always has been, INCREDIBLY speculative. Every patent secured and every minor progress update has only served to partially reduce the risk, but it is still entirely 100% critical that either the biochip or 12CQ come to market. There is no other possible revenue stream or backup plan. It simply just has to work. Both are incredibly innovative, and therefore very difficult. The SP may go down to 0.1c, or it may hold steady. There is very little correlation to share price and and waking up one day to an announcement that they have create a fully working prototype and ready for securing a mass production contract. On such day, if it occurs, it doesn't matter if the SP is 0.1c or $3, this is when it will sky-rocket. And continue to grow with revenue streams secured by the patents.
Until then, share price is irrelevant. It was never going to steadily grow, although it would be nice if it did. We are wholly and 100% dependent on a work product coming to market in order to realise this investment.
There is no immediate concerns as they have plenty enough cash to keep going for the next 12months+ (or more) so there is no point selling out now, unless you want to secure missing out on the whole reason why you invested in the first place; not to make 20% but to make 2,000%+ profit.
AXE Price at posting:
43.0¢ Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)